Dr. Yardena Samuels on Targeting Pathways Instead of Proteins in Melanoma

March 1, 2016
Yardena Samuels, PhD

Yardena Samuels, PhD, on the ineffectiveness of targeting a single gene of proteins in patients with melanoma. Samuels says this strategy may work for the short term for treatment, but patients would tend to develop a resistance much quicker to treatment strategies using this method.

Yardena Samuels, PhD, Department of Molecular Cell Biology, Weizmann Institute of Science, discusses the ineffectiveness of targeting a single gene of proteins in patients with melanoma. Samuels says this strategy may work for the short term for treatment, but patients would tend to develop a resistance much quicker to treatment strategies using this method.